Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | Inhibition of human brain MAOA | ChEMBL. | 18834112 | |
Activity (functional) | = 9.66 | Beta-blocking activity of the compound was measured by applying the stepwise linear discriminate analysis; Active | ChEMBL. | No reference |
Activity (functional) | = 9.66 | Beta-blocking activity of the compound was measured by applying the stepwise linear discriminate analysis; Active | ChEMBL. | No reference |
ISA (functional) | Tested for intrinsic sympathomimetic activity (ISA); antagonist with partial agonistic properties | ChEMBL. | 2903243 | |
ISA (functional) | 0 | Tested for intrinsic sympathomimetic activity (ISA); antagonist with partial agonistic properties | ChEMBL. | 2903243 |
Ki (binding) | = -5.05 | Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabelled [3H]-8-OH-DPAT ligand displacement | ChEMBL. | 8568799 |
Ki (functional) | = 313 uM | TP_TRANSPORTER: inhibition of Taxol transepithelial transport (basal to apical) in Caco-2 cells | ChEMBL. | 11405287 |
LD50 (ADMET) | = 42.8 mg kg-1 | Compound was tested for its toxicity after intravenous administration to mice in experiment 2 | ChEMBL. | No reference |
LD50 (ADMET) | = 56.2 mg kg-1 | Compound was tested for its toxicity after intravenous administration to mice in experiment 1 | ChEMBL. | No reference |
LD50 (ADMET) | = 1768.5 mg kg-1 | Compound was tested for its toxicity after oral administration to mice in experiment 2 | ChEMBL. | No reference |
LD50 (ADMET) | = 1834 mg kg-1 | Compound was tested for its toxicity after oral administration to mice in experiment 1 | ChEMBL. | No reference |
Log Ki (binding) | = 5.05 | Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabelled [3H]-8-OH-DPAT ligand displacement | ChEMBL. | 8568799 |
Selectivity (binding) | Selectivity for beta1 receptor | ChEMBL. | 2903243 | |
Selectivity (binding) | Selectivity of the compound towards beta-2 adrenergic receptor;Not selective towards beta-2 adrenergic receptor | ChEMBL. | 2903243 | |
Selectivity (binding) | 0 | Selectivity for beta1 receptor | ChEMBL. | 2903243 |
Selectivity (binding) | 0 | Selectivity of the compound towards beta-2 adrenergic receptor;Not selective towards beta-2 adrenergic receptor | ChEMBL. | 2903243 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
4 literature references were collected for this gene.